R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 1999

Primary Completion Date

April 30, 2001

Study Completion Date

April 30, 2001

Conditions
Leukemia
Interventions
DRUG

tipifarnib

Trial Locations (3)

14642

University of Rochester Cancer Center, Rochester

21201

Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore

52242

University of Iowa College of Medicine, Iowa City

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Maryland, Baltimore

OTHER

NCT00004009 - R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia | Biotech Hunter | Biotech Hunter